Nanoscale Drugs Carriers in Chronic Diseases Treatment: Applications

1Dr. Swati Mishra, Dr. Debasish Samal

186 Views
69 Downloads
Abstract:

Nanomedicines address traditional therapy shortcomings, as shown by many preclinical and clinical studies that indicate site-specific drug delivery, decreased side effects, and better treatment result. Developing appropriate and the biocompatible drug delivery vehicles is a prerequisite effectively achieved through the use of simple and functional liposomes, hydrogels, nanoparticles, and dendrimers, micelles, and mesoporous particulates. Nanomedicine plays a key role for applications like the delivery and diagnosis of drugs in the medical field. Over the last decade, the need to build multiple systems that may distribute the pharmaceutical agent accurately and directly to the target site has expanded. Across medical fields such as cardiology, oncology, and immunology these programs have a major impact. However, it still needs a large number of extensive clinical trials to make sure the short-and long-term effects of the nanomedicines in humans. Smart drug delivery systems with the stimuli response, such as temperature, pH, illumination, electrical, ultrasound, and magnetic fields were developed in this regard. Several nanoparticles, including silver NPs, gold NPs, magnetic NPs, quantum dots, and mesoporous silica NPs, have been studied as nanocarriers for drug targeting.

Keywords:

Cancer Therapy, Cardiovascular Diseases, Diabetes, Nanomedicine, Stimuli Responsive, Targeted Drug Delivery

Paper Details
Month12
Year2019
Volume23
IssueIssue 6
Pages402-408

Our Indexing Partners

Scilit
CrossRef
CiteFactor